Alzamend Neuro Inc (ALZN): A Case For Going Higher

After Hours

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Alzamend Neuro Inc is $7.48M. A total of 0.51 million shares were traded on the day, compared to an average of 1.65M shares.

In the most recent transaction, AULT MILTON C III bought 75 shares of ALZN for 2.75 per share on Aug 06 ’24. After the transaction, the Director now owns 77,268 company shares. In a previous transaction on Jul 31 ’24, AULT MILTON C III bought 25 shares at 3.74 per share. ALZN shares that Director owns now total 77,193.

Among the insiders who bought shares, AULT MILTON C III acquired of 1,000 shares on Apr 19 ’24 at a per-share price of $0.69. This resulted in the Director holding 771,699 shares of ALZN after the transaction. In another insider transaction, AULT MILTON C III bought 334 shares at $0.91 per share on Apr 01 ’24. Company shares held by the Director now total 770,699.

Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, ALZN has a high of $32.99 and a low of $1.40.

Balance Sheet Annually/Quarterly

In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. ALZN’s latest balance sheet shows that the firm has $14.06M in Cash & Short Term Investments as of fiscal 2022. There were $335.30k in debt and $1.16M in liabilities at the time. Its Book Value Per Share was -$1.41, while its Total Shareholder’s Equity was $13.35M.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ALZN is Buy with a score of 3.50.

Most Popular

Related Posts